Ed Arce

Stock Analyst at HC Wainwright & Co.

(1.63)
# 1599
Out of 5,266 analysts
570
Total ratings
45.01%
Success rate
10.96%
Average return
57 Stocks
Name Action Price Target Current % Upside Ratings Updated
Ultragenyx Pharmaceu...
Reiterates: Buy
95 95
44.24 114.74% 6 Feb 18, 2025
Arcturus Therapeutic...
Reiterates: Buy
63 63
16.64 278.61% 29 Feb 18, 2025
Pliant Therapeutics
Reiterates: Neutral
n/a
n/a n/a 22 Feb 14, 2025
Enanta Pharma
Reiterates: Buy
18 18
8.22 118.98% 11 Feb 11, 2025
Genfit
Reiterates: Buy
13 13
3.85 237.66% 18 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
2.58 403.88% 14 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
0.6 566.67% 25 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 72
50.39 42.89% 24 Jan 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
1.91 292.67% 34 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
29 29
11.06 162.21% 21 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.4 47.06% 18 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
0.62 867.74% 5 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
6 6
5.8 -5.17% 8 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 22
23.42 -6.06% 20 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48 48
18.76 155.86% 2 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
390 400
345.63 15.73% 16 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
0.68 1664.71% 16 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
1.64 631.71% 1 Dec 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 16 Dec 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 7 Dec 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8 8
4.21 78.15% 11 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32 32
4.11 678.59% 9 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
66 66
53.01 24.5% 29 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24 24
22.27 7.77% 21 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
75 75
21.11 255.28% 4 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.51 231.13% 13 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
7.87 65.18% 16 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
12 240
n/a n/a 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 8 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
33
n/a n/a 20 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
29.89 -16.36% 8 Dec 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 8 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
3
n/a n/a 12 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
40
n/a n/a 4 Jun 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 5 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
42
n/a n/a 10 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 69
n/a n/a 1 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6 2
n/a n/a 4 Mar 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 39
n/a n/a 8 Nov 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Oct 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13500 14625
1.4 1044542.86% 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1750 0
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 12, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
2188
1.67 130888.02% 4 May 31, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 15
n/a n/a 3 Mar 22, 2019